Allergy Immunotherapy Market Growth in Future Scope 2024-2031 | Stallergenes Greer, ALK-Abello A/S, Allergy Therapeutics, Allergopharma, HAL Allergy Group

The Allergy Immunotherapy Market is estimated for 2023 for the forecast period 2024-2031, as highlighted in a new report published by Coherent Market Insights.

Market Overview:

Allergy immunotherapy, also known as desensitization or hypo-sensitization, involves exposing people to allergen extracts (e.g., pollen, dust mites, pet dander) to decrease the symptoms caused by allergies. The immunotherapy products help in the management of respiratory allergies like allergic rhinitis, asthma.

Market Dynamics:

The growth of the allergy immunotherapy market is majorly driven by the increasing prevalence of allergic diseases such as asthma, allergic rhinitis, food allergies, and others. According to a report by the American Academy of Allergy Asthma and Immunology, more than 50 million Americans suffer from allergies each year. Moreover, subcutaneous immunotherapy is projected to gain immense traction in the market as it offers long-lasting allergen-specific relief. This treatment involves injecting dilute amounts of allergens under the skin to build up tolerance and a clinical goal of reducing adverse reactions. The other key driver impacting market growth is rising awareness regarding the benefits of immunotherapy over conventional allergy medications like antihistamines, decongestants

Sample Copy of Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/4915

Leading Key Players Include in This Report:

Stallergenes Greer, ALK-Abello A/S, Allergy Therapeutics, Allergopharma, HAL Allergy Group, Aimmune Therapeutics, DBV Technologies, Leti Pharma, and Jubilant HollisterStier

Since the report focuses on the healthcare sector, it also sheds light on key development in the said industry and latest R&D activities. It educates business owners on newly approved products, ongoing research and development, and products under the trial phase and in the pipeline.

Detailed Segmentation:

Global Allergy Immunotherapy Market, By Treatment Type:
Subcutaneous Immunotherapy (SCIT)
Sublingual Immunotherapy (SLIT)

Global Allergy Immunotherapy Market, By Allergy Type:
Allergic Rhinitis
Allergic Asthma
Food Allergy
Venom Allergy
Others

Global Allergy Immunotherapy Market, By Distribution Channel:
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

Major Driver: Increasing Prevalence of Allergies Across the Globe

The prevalence of allergies has been steadily rising across both developing and developed countries in recent decades. According to research, an estimated 500 million people worldwide suffer from respiratory allergies like allergic rhinitis and asthma. Asthma alone affects an estimated 235-300 million people globally. This rise in allergic disorders has been attributed to factors like increasing environmental pollution, changes to modern lifestyle and diet, and lack of early childhood exposure to infectious diseases and microbes. As more people are diagnosed with allergies, the demand for effective treatment and management options like allergy immunotherapy is increasing correspondingly. Many patients who once relied on temporary symptom relief from medications are now opting for long term management through allergy shots or sublingual immunotherapy tablets.

Major Restrain: High Cost of Treatment

While allergy immunotherapy promises benefits over long term use, the initial costs involved can still pose a restrain for widespread adoption especially in price-sensitive and value-based healthcare markets. Treatment typically comprises of weekly doctor visits over 3-5 years and involves the use of customized allergen extracts and immunotherapeutic preparations. The costs vary depending on the type of allergen, method of delivery via injections or sublingual tablets, and duration of therapy required. For complex multi-allergen formulas, an entire AIT course may cost several thousand dollars in the US, making it unaffordable for many. The high costs can deter patients and payers when weighed against cheaper symptomatic therapy. Efforts to develop shorter, more effective treatments and establish allergy clinics to increase access and bring costs down could help address this barrier.

Market Restraints:

To Purchase Report, Click Here @ https://www.coherentmarketinsights.com/insight/buy-now/4915

Major Opportunity: Expanding Applications to More Patient Groups

While most of the current allergy immunotherapy offerings target common airborne allergies like pollen, dust mites, and pet dander, industry players see potential in developing AIT options for other allergic conditions as well. Areas representing key opportunities include food allergies, venom allergies from bee stings, and allergic asthma triggered by certain allergens. Successful applications in these areas could tap into a much larger market. Other opportunities lie in novel product improvements like sublingual tablets and drops that offer easier dosing at home compared to injections. Adjuvanted formulations promising faster efficacy could also appeal to more patients. With ongoing innovation and clinical evidence, the eligible patient pool for allergy immunotherapy is expected to multiply, driving further adoption and revenue prospects over the long term.

Major Trend: Consolidation of Players and Influx of Large Pharma

There is a notable trend of consolidation occurring in the allergy immunotherapy market space as smaller companies get acquired by major pharma giants seeking to strengthen their portfolio in this field. For instance, in 2017, Stallergenes Greer was acquired by Ares Life Sciences, while ALK-Abello completed its merger with HAL Allergy Group to form one of the largest global players called HAL Allergy. Such deals allow the bigger companies access to complementary product lines and geographical markets, enabling new synergies. At the same time, pharma majors like Merck, Sanofi and GSK are pumping in R&D investments to discover novel therapies and delivery platforms. This influx of larger well-established players augurs well for increased funding availability towards innovation and clinical development.

Key Region/Countries are Classified as Follows:

» North America (United States, Canada, and Mexico)
» Europe (Germany, France, UK, Russia, Italy)
» Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)
» Latin America (Brazil, Argentina, Colombia)
» Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)

Reason to Buy Our Market Research Report

✤ Strategic Decision-Making: This Market research reports offer comprehensive and reliable data, analysis, and insights about a market. By accessing this information, businesses can make well-informed strategic decisions Allergy Immunotherapy market entry, product development, target audience identification, competitive positioning, and growth opportunities.

✤ Market Understanding: These research reports provide a deep understanding of the market dynamics, trends, and factors influencing customer behavior. This understanding helps businesses identify market gaps, emerging opportunities, and potential threats, enabling them to adapt their strategies and offerings accordingly.

✤ Competitive Intelligence: This Market research reports analyze the competitive landscape by examining key competitors, market share, strengths, weaknesses, strategies, and customer preferences. This information allows businesses to benchmark their performance, identify competitive advantages, and develop effective strategies to outperform their rivals.

✤ Customer Insights: This Market research reports often include data and analysis on customer demographics, preferences, buying behaviors, and satisfaction levels. This information helps businesses understand their target audience better, tailor their products or services to meet customer needs, and develop effective marketing and communication strategies.

✤ Risk Mitigation: This Market research reports enable businesses to assess the potential risks and challenges associated with entering or expanding into a market. By understanding market dynamics, regulatory factors, economic conditions, and industry trends, businesses can mitigate risks, avoid costly mistakes, and make informed decisions that align with their objectives.

✤ Investment and Funding Decisions: This Market research reports provide credible data and analysis that can support investment decisions. They help businesses present a clear picture of the market opportunity, potential ROI, and growth prospects, making it easier to secure funding or attract investors.

✤ Validation and Credibility: Allergy Immunotherapy Market research reports offer independent and unbiased analyses conducted by industry experts. This lends credibility to the information presented and enhances the trust and confidence of stakeholders, including investors, partners, and customers.

✤ Long-term Business Planning: This Market research reports provide a foundation for long-term business planning. They offer insights into market trends, growth projections, and emerging opportunities, allowing businesses to develop sustainable strategies and stay ahead in a competitive market.

Get Customized Report @ https://www.coherentmarketinsights.com/insight/request-customization/4915

How does the Report Aid Your Business Discretion?

➥ This section of Allergy Immunotherapy Market report highlights some of the most relevant factors and growth enablers that collectively ensure a high-end growth spurt
➥ The report unravels details on pronounced share assessments across both country-wise as well as region-based segments
➥ A leading synopsis of market share analysis of dynamic players inclusive of high-end industry veterans
➥ New player entry analysis and their scope of new business models
➥ The report includes strategic recommendations for new business veterans as well as established players seeking novel growth avenues
➥ A detailed consultation services based on historical as well as current timelines to ensure feasible forecast predictions
➥ A thorough evaluation and detailed study of various segments as well as sub-segments across regional and country-specific developments
➥ Details on market estimations, market size, dimensions and the like
➥ A review of market competitors, their high-end product and service portfolios, dynamic trends, as well as technological advances that portray high end growth in this Market

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐔𝐬:
Mr. Shah
Coherent Market Insights Pvt. Ltd,
📞Phone: U.S.: +1-206-701-6702
📞U.K.: +44-020-8133-4027
📞JAPAN: +81-50-5539-1737
📞INDIA: +91-848-285-0837
✉ Email: sales@coherentmarketinsights.com

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

This release was published on openPR.